Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis in Immunocompromised Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

201

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

Herpes Labialis

Interventions

DRUG

ME-609

Dosage form: Cream Dose and regimen: 5 times daily during 5 days Route of administration: Topical application

DRUG

Acyclovir in ME-609 vehicle (5% acyclovir)

Dosage form: Cream Dose and regimen: 5 times daily during 5 days Route of administration: Topical application